Faculty profile

Haibo Zhang

ResearcherAnesthesiaUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Haibo Zhang

Researcher

Anesthesia

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
34 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (7 CIHR, 1 SSHRC), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

124

Publications

831

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Biomedical Research Development Of New Therapeutics Microbiology& Infection Diseases Bone-Marrow-Derived Mesenchymal Stromal Cells (Msc)Cytokines Endotoxin Icam-1 Lung Injury

Latest papers

Remimazolam besylate in the intensive care unit: emerging evidence, unresolved questions, and a potential clinical niche.
Intensive care medicine · 2026
Ultra-low versus low tidal volume ventilation in acute respiratory distress syndrome: a systematic review and meta-analysis.
Journal of thoracic disease · 2026
Obesity and early sepsis-associated acute respiratory distress syndrome: A prospective multicenter study.
Respiratory medicine · 2026

All 124 publications

Latest funding

Accelerating and standardizing assessment of acute lung injury using an artificial intelligence based approach
CIHR · 2024 · Co-investigator
$100,000
Aiming at a new target in endotoxin-associated lung damage: The Ig domain 3 of ICAM-1
CIHR · 2023 · Nominated PI
$982,260
Aiming at a novel target in endotoxin-associated lung damage: The Ig domain 3 of ICAM-1
CIHR · 2022 · Nominated PI
$100,000

All 15 grants and awards

124 publications.

Remimazolam besylate in the intensive care unit: emerging evidence, unresolved questions, and a potential clinical niche.

Yang X, Zhang H, Shang Y

Intensive care medicine2026

DOI: 10.1007/s00134-026-08526-y PMID: 42307659

Ultra-low versus low tidal volume ventilation in acute respiratory distress syndrome: a systematic review and meta-analysis.

Wang Y, Songsangvorn N, Li J, Chen X, Xie J, Pi Y, Yang X, Liu Q, Liu X, Zhang H, Xu Y

Journal of thoracic disease2026

DOI: 10.21037/jtd-2026-0573 PMID: 42444952

Obesity and early sepsis-associated acute respiratory distress syndrome: A prospective multicenter study.

Zhao L, Li Y, Lin X, Cui Q, Liu J, Yang F, Wang Y, Wang J, Liu Y, Shi X, Cao D, Li J, Su F, Zhang H, Xie K

Respiratory medicine2026

DOI: 10.1016/j.rmed.2026.109007 PMID: 42401374

A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to inhibit infection and lung injury.

Liang J, Onodera Y, Li Y, Wu J, McColman S, Cramb DT, Khang J, Khine AA, Chen YW, Rotstein OD, Mubareka S, Slutsky AS, Zhang H

Journal of translational medicine2026Senior author

DOI: 10.1186/s12967-026-08333-5 PMID: 42288894

The new SOFA for sepsis identification and mortality prediction: a multicenter cohort study.

Zhao L, Cui Q, Liu J, Dong S, Zong L, Yang F, Shi H, Wang Y, Zhao X, Li H, Fang Y, Gao Y, Pei H, Su F, Zhang H, De Backer D, Li Y, Xie K

Journal of intensive care2026

DOI: 10.1186/s40560-026-00891-6 PMID: 42192473

Inhibition of PADI2-mediated vimentin citrullination alleviates silica-induced pulmonary fibrosis in mice.

Jin F, Li Y, Li T, Liu S, Xu D, Liu H, Wei Z, Gao X, Mao N, Cai W, Shi Y, Zhang H, Xu H

Particle and fibre toxicology2026

DOI: 10.1186/s12989-026-00671-y PMID: 41794752

Severe hypotension but not systemic inflammation or endothelial activation predicts encephalopathy in circulatory shock.

Nguyen DN, Huyghens L, Nguyen TM, Schiettecatte J, Diltoer M, Cools W, De Cuyper H, Rhapsorski D, Smitz J, Zhang H

Annals of intensive care2026Senior author

DOI: 10.1016/j.aicoj.2026.100033 PMID: 41788477

Mesenchymal stromal cells engineered with ACE2 for treatment of receptor-mediated viral lung injury.

Li Y, Liang J, Zhang Z, Rotstein O, Nakane M, Wybenga-Groot L, Khang J, Khine AA, Xu Y, Li Y, Orser BA, Laffey JG, Matthay M, Slutsky AS, Mubareka S, Zhang H

Molecular therapy : the journal of the American Society of Gene Therapy2026Senior author

DOI: 10.1016/j.ymthe.2025.11.020 PMID: 41241773

Exploring the role of inflammation and proinflammatory proteins in coagulopathy during venovenous extracorporeal membrane oxygenation.

Wang Y, Sun H, Zhang J, Xie X, Yu Y, Liang Z, Ye W, Zeng Z, Luo X, Liu D, Xi Y, Zhang R, Yang C, Zhou L, Li M, Pan J, Xu Z, Sang L, Xu Y, He W, Zhang H, Liu X, Li Y, Xu Y

Thrombosis research2025

DOI: 10.1016/j.thromres.2025.109358 PMID: 40441037

Targeting the Secretin Receptor in Macrophages Attenuates Silica-Induced Pulmonary Fibrosis.

Li Y, Li T, Jin F, Liu S, Xu D, Wei Z, Gao X, Cai W, Mao N, Yang F, Zhang H, Shi Y, Xu H

Cell proliferation2025

DOI: 10.1111/cpr.70131 PMID: 40967637

Something wrong or missing on this profile? Suggest a correction

Haibo Zhang

Research

Latest papers

Latest funding

Remimazolam besylate in the intensive care unit: emerging evidence, unresolved questions, and a potential clinical niche.

Ultra-low versus low tidal volume ventilation in acute respiratory distress syndrome: a systematic review and meta-analysis.

Obesity and early sepsis-associated acute respiratory distress syndrome: A prospective multicenter study.

A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to inhibit infection and lung injury.

The new SOFA for sepsis identification and mortality prediction: a multicenter cohort study.

Inhibition of PADI2-mediated vimentin citrullination alleviates silica-induced pulmonary fibrosis in mice.

Severe hypotension but not systemic inflammation or endothelial activation predicts encephalopathy in circulatory shock.

Mesenchymal stromal cells engineered with ACE2 for treatment of receptor-mediated viral lung injury.

Exploring the role of inflammation and proinflammatory proteins in coagulopathy during venovenous extracorporeal membrane oxygenation.

Targeting the Secretin Receptor in Macrophages Attenuates Silica-Induced Pulmonary Fibrosis.

Reconstruction of a diseased lung using bioengineering approach

Developing organ-on-a-chip models of COVID-19_x000d_

Frequent collaborators

Mingyao Liu

Ori Rotstein

Samira Mubareka

Karen Burns

Matteo Parotto

Lorenzo Del Sorbo

Heyu Ni

Patricia Chia-Ying Liaw

Kieran Quinn

Katalin Szaszi

Xiao-Yan Wen

Alison Fox-Robichaud

Nanshan Zhong

Stefanos Voglis

Tianru Jin

Laurent Brochard

Andras Kapus

Jane Batt

Bernard Thébaud

Andrew Baker

Claudia Dos Santos

Martin Post

Armand Keating

Mohammed Al-Omran

Hwee Teoh

George Yousef

Neil Goldenberg

Braedon McDonald

Finlay Maguire

Haibo Qiu

Theo Moraes

Leonardo Susta

Ryan McGinn

Deborah Cook

Beverley Orser

Lauralyn McIntyre

Warren Lee

Paul Kubes

Arthur Slutsky

Micheline Piquette-Miller